• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • The Longest-Running Evolution Experiment Has Been Going For 80,000 Generations
  • From Shrink Rays And Simulated Universes To Medical Mishaps And More: The Stories That Made The Vault In 2025
  • Fastest Cretaceous Theropod Yet Discovered In 120-Million-Year-Old Dinosaur Trackway
  • What’s The Moon Made Of?
  • First Hubble View Of The Crab Nebula In 24 Years Is A Thing Of Beauty… With Mysterious “Knots”
  • “Orbital House Of Cards”: One Solar Storm And 2.8 Days Could End In Disaster For Earth And Its Satellites
  • Astronomical Winter Vs. Meteorological Winter: What’s The Difference?
  • Do Any Animal Species Actively Hunt Humans As Prey?
  • “What The Heck Is This?”: JWST Reveals Bizarre Exoplanet With Inexplicable Composition
  • The Animal With The Strongest Bite Chomps Down With A Force Of Over 16,000 Newtons
  • The Eschatian Hypothesis: Why Our First Contact From Aliens May Be Particularly Bleak, And Nothing Like The Movies
  • The Great Mountain Meltdown Is Coming: We Could Reach “Peak Glacier Extinction” By 2041
  • Comet 3I/ATLAS Is Experiencing A Non-Gravitational Acceleration – What Does That Mean?
  • The First Human Ancestor To Leave Africa Wasn’t Who We Thought It Was
  • Why Do Warm Hugs Make Us Feel So Good? Here’s The Science
  • “Unidentified Human Relative”: Little Foot, One Of Most Complete Early Hominin Fossils, May Be New Species
  • Thought Arctic Foxes Only Came In White? Think Again – They Come In Beautiful Blue Too
  • COVID Shots In Pregnancy Are Safe And Effective, Cutting Risk Of Hospitalization By 60 Percent
  • Ramanujan’s Unexpected Formulas Are Still Unraveling The Mysteries Of The Universe
  • First-Ever Footage of A Squid Disguising Itself On Seafloor 4,100 Meters Below Surface
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version